Navigation Links
MGT Capital Investments Reports Third Quarter 2007 Financial Results and Provides Update on Recent Developments
Date:11/9/2007

NEW YORK, Nov. 9 /PRNewswire-FirstCall/ -- MGT Capital Investments, Inc. (Amex: MGT), a holding company focused on the Healthcare Information Technology sector, today reported financial results for the third quarter ended September 30, 2007 and provided an update on strategic milestones.

Tim Paterson-Brown, MGT Chairman and CEO, stated, "We are excited about the significant progress that our company and its subsidiaries made in the third quarter. Most notably, our Medicsight subsidiary reported initial revenue for its CAD software, which received European approval earlier this year, and completed its initial public offering on the London Stock Exchange's AIM market in June 2007. We anticipate revenues from Medicsight's CAD software to ramp up quickly over the fourth quarter and 2008 through strategic distribution agreements with some of the world's largest virtual colonoscopy software providers.

"In addition, a major independent study funded by the U.S. National Institute of Health and conducted by the American College of Radiology Imaging Network (ACRIN) recently released definitive results supporting the use of virtual colonoscopies when screening for colorectal cancer. This study solidifies the message that we have been championing for some time now, which is that medical imaging offers the best solution for screening the growing number of people 50 years old and older for colorectal cancer. We believe this study will lead to a material increase in the use of virtual colonoscopies for screening worldwide."

Paterson-Brown continued, "Our Medicexchange subsidiary is also beginning to gain traction in the market, experiencing over 850% growth in monthly traffic since January 2007. We are concentrating on building up the site's content, with more than 200 sources currently supplying updated news and articles. Medicexchange has also been increasing the number of vendor agreements with medical software providers worldwide."

Recent Developments

1 Tim Paterson-Brown, MGT Chairman and CEO, acquired 250,000 shares of MGT

common stock from an existing shareholder in a single private

transaction at $3.75 per share, for $937,500.

2 MGT announced recent commercial partnerships for its subsidiary company

Medicexchange PLC, a global web portal that delivers sales, jobs and

information channels for diagnostic, treatment and surgery planning

solutions across breast imaging, cardiac imaging, musculoskeletal

imaging, abdominal-pelvic imaging, thoracic imaging and neuro imaging

from a range of different companies. The first partnership is with

AllHealthcareJobs.com, whereby Medicexchange utilizes the

AllHealthcareJobs.com job bank search engine to populate

jobs.medicexchange.com. The second partnership is with Valley Forge

Publishing Group (VFPG) who have signed an exclusive agreement to be

Medicexchange's sole advertising agent.

3 MGT recently engaged KCSA Worldwide as the Company's new outside

Investor Relations firm. In doing so, it is the Company's intention to

provide shareholders with an additional avenue through which they can

garner better insight into the MGT story and to more effectively reach

its rapidly expanding roster of existing and potential investors.

Financial Results for the nine months ended September 30, 2007

For the nine months ended September 30, 2007 and September 30, 2006 our revenues from operations were $12,000 and $0, resulting from the sale of Medicsight software licenses.

Total operating expenses in nine month period ended September 30, 2007 were $14.1 million, compared to total operating expenses of $11.3 million for the nine month period ended September 30, 2006. The increase in operating expenses is attributable in part to costs related to Medicsight's IPO.

For the nine month period ended September 30, 2007, net loss was $9.8 million, or $0.25 per diluted share, compared to a net loss of $10.9 million, or $0.29 per diluted share, in the same period in 2006.

As of September 30, 2007, cash balances equivalents were $99.6 million, compared to $19.8 million at December 31, 2006. The increase in cash balance is attributable to the net proceeds of $61.1 million that the Company received following the listing of its subsidiary on the AIM market.

About MGT Capital Investments, Inc.

MGT Capital Investments, Inc is a holding company that focuses on investments in the global healthcare information technology market. The Company has two subsidiaries, Medicsight PLC and Medicexchange PLC.

Medicsight PLC (traded on the AIM market of the London Stock Exchange, under the Ticker symbol MDST) is a medical imaging software development company developing enterprise-wide Computer-Aided Detection (CAD) software which analyzes computer tomography (CT) scans for the early detection and measurement of colorectal polyps and lung lesions. Medicsight has focused on two of the leading causes of cancer-related death, colorectal cancer and lung cancer.

Medicexchange PLC provides medical imaging professionals with a global web portal containing an online sales, jobs and information channel for diagnostic, treatment and surgery planning solutions. This combined with a variety of relevant clinical papers, training materials and content gives these professionals access to information and products that they otherwise would have difficulty accessing.

Additional information can be found at http://www.mgtci.com.

All forward-looking statements are made pursuant to the 'safe harbor' provisions of the Private Securities Litigation Reform Act of 1995. Forward- looking statements are based on current management expectations that involve risks and uncertainties that may result in such expectations not being realized. Potential risks and uncertainties include, but are not limited to, the risks described in company filings with the Securities and Exchange Commission.

For further information: Media enquiries:

MGT Capital Investments KCSA Worldwide

Alex van Klaveren Todd Fromer / Garth Russell

Tel: +1 646-257-2644 Tel: +1 212-896-1215 / 212-896-1250

alex@mgtci.com tfromer@kcsa.com / grussell@kcsa.com

http://www.mgtci.com


'/>"/>
SOURCE MGT Capital Investments, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
2. AtriCure to Present at Roth Capital Partners 2007 New York Conference
3. Doctors and medical ethicist discuss whether doctors should participate in capital punishment
4. Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment
5. Osteotech to Present at First Albany Capitals Regenerative Technologies Conference in New York
6. iCAD to Present at Americas Growth Capital 4th Annual Emerging Growth Conference
7. Pharsight Files Application for Nasdaq Capital Market Listing
8. Advanced Life Sciences Joins NASDAQ Capital Market
9. Foundation Venture Capital Group, LLC Invests in Start Up Committed to Breast Cancer Diagnostics
10. Bally Total Fitness Emerges From Chapter 11 and Closes Transaction with Harbinger Capital Partners Funds
11. Caxton-Iseman Capital Acquires Conney Safety Products, LLC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... ... April 24, 2017 , ... The bar for just about everything—apparel, eyewear, cars ... rarified air of pop and film stardom.(1) Not to be left out is that ... Grins now run the gamut from being encrusted with jewels and precious metals to, ...
(Date:4/24/2017)... Chicago, Illinois (PRWEB) , ... April 24, 2017 , ... ... home. What happened next changed her life forever. , In “Healing Tears,” James depicts ... “At the advice of my attorney, I began journaling conversations and situations throughout my ...
(Date:4/24/2017)... Raton, Florida (PRWEB) , ... April 24, 2017 , ... ... chai teas, announced its products are now available for purchase on RevNutrition.com, a popular ... form of tea first produced and popularized in ancient India and Siam. It spread ...
(Date:4/24/2017)... CA (PRWEB) , ... April 24, 2017 , ... ... brain tumors are expected to be diagnosed globally; approximately 25,000 of them will ... are anticipating greater use of this type of healthcare model in the diagnosis ...
(Date:4/24/2017)... CA (PRWEB) , ... April 24, 2017 , ... As ... is worth a thousand words. The good news for single women is that she ... Attraction," which is available on April 25th. Joan's insight, personal experiences and sparkling sense ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, today ... C virus (HCV) infected patients with genotype 1, ... (Child-Pugh A) achieved sustained virologic response at 12 ... pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high SVR ... of G/P treatment without ribavirin. Patients with specific ...
(Date:4/19/2017)... - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), announces that ... Conference 2017 at the Sheraton Hotel in Toronto, Ontario ... of the Company is scheduled to present on Tuesday, May 2 ... the Chairman of the Board, Tony Holler will also ... For more ...
(Date:4/19/2017)... April 19, 2017 Global Prostate Cancer ... on the prostate cancer therapeutics market analyzes the ... Increasing prevalence of prostate cancer, launch of promising ... development of new drugs & therapeutic biological products, ... due to lesser side effects are some of ...
Breaking Medicine Technology: